Results
The primary outcome (stroke, death, and MI) was seen in 2.9% of elderly patients, with increasing risk across the age groups, which was statistically significant for trend (P=0.003). The overall mortality rate was 0.5%, and it was highest in the >85 years group at 1.7%. There was a statistically significant trend across the various age groups (P=0.002). In symptomatic patients, the combined risk of death, stroke, and MI was higher in the age >75 years group (3.5%) compared with the age 70 to 74 years group (2.8%), but not statistically different (P=0.472). In asymptomatic patients, mortality was significantly higher in the age >75 group compared with the age 70 to 74 years group (0.7%
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April 2013 vs 0.0%; P=0.006), and the combined risk of death, stroke, and MI was 3.1% in the age >75 years group compared with 2.0% in the age 70 to <74 years group (P=0.08; Table 2 ). The adjusted odds ratio of the combined outcome of stroke, death, and MI was 2.26 in the age >85 years group compared with the age 70 to 74 years group, which was statistically significant (95% confidence interval, 1.27-4.2; Figure) .
Discussion
In the CARE Registry, we found significant differences in perioperative mortality within groups of elderly patients undergoing CEA. This was in spite of the fact that the risk of MI or perioperative stroke or transient ischemic attack was not significantly higher in those aged >85 years. Thus, the higher mortality was likely related, at least in part, to complications other than stroke and MI. Stroke risk factors, including diabetes mellitus, smoking status, and dyslipidemia, were less prevalent in older groups. In spite of the potential advantage, they had higher mortality and risk of the combined outcome of stroke, death, and MI. The worse outcomes in the patients aged >85 years are mostly attributable to worse outcomes in asymptomatic group. There was significantly higher mortality among asymptomatic patients undergoing CEA in those age >85 years compared with those in the age 70 to 74 years group. By some estimates, >90% of patients undergoing CEA in the United States are asymptomatic patients in spite of national guidelines recommending CEA only in highly selected patients. This trend is reflected in the CARE Registry, in which far more CEA procedures were performed for asymptomatic patients.
Strengths of this study are as follows: (1) a robust national sample from 171 hospitals; (2) prospectively collected data with rigorous attention to detail; and (3) contrary to randomized clinical studies in which the inclusion and exclusion were stringent, our study is more reflective of contemporary practice. This analysis represents a good estimate of the real-world outcomes of the CEA procedure in elderly. 
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Limitations
CARE registry does not include all US hospitals that perform CEA. The primary end point (stroke, death, and MI) in our study was lower than some randomized studies, such as CREST, in which the combined risk of stroke, death, and MI among patients aged >75 years undergoing CEA was 5.9%. This could, in part, be because the primary outcome we chose was in-hospital, whereas randomized studies have 30-day events. There was also no standardized method to determine degree of carotid stenosis.
Conclusions
The majority of CEA procedures in patients aged >70 years reported in the CARE registry are performed for asymptomatic stenosis. CEA should be carefully weighed in asymptomatic patients, especially when they are older. Overall, the perioperative risk of complications after CEA in the elderly is within widely accepted guidelines. There are significantly higher rates of the composite of stroke, MI, and death with increasing age >70 years, for patients undergoing CEA.
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Figure. Forrest plot showing effect of age on adjusted odds ratio (OR) of the primary outcome of stroke, death, and myocardial infarction (MI), (compared with the age 70-74 years group). CI indicates confidence interval.
